Usana passes $1 billion mark with strong Asia growth
Usana Health Sciences passed the $1 billion mark in annual sales with a strong year-end earnings report that included strong growth in key markets in Asia.
Archives for February 14, 2018
Dispatches from IPA World Congress + Probiota 2018
Carbiotix launches world's lowest cost microbiome test
A new low-cost microbiome testing service — priced at between €9 and €19 per month — will make monthly microbiome insights possible for the mass market consumer, said Carbiotix CEO Kristofer Cook as he announced the service as part of his talk at the IPA...
Regular intake of energy-reduced foods may help stave off obesity and diabetes: Singapore study
Regularly consuming food and drink (be they sweet or savoury) that are less energy-dense could help to lower overall energy intake and postprandial blood glucose concentration, say researchers in Singapore.
Small amounts of prebiotics increase SCFA production through effect on colonic microbiota: Study
Relatively small doses of prebiotics may be able to increase the body's production of health-boosting short-chain fatty acids (SCFAs) by activating the metabolism of human colonic microbiota, according to researchers in Japan.
Vitamin D deficiency putting young people in Hong Kong at greater risk of cardiometabolic disease
Public health strategies for increasing vitamin D intake among young people are urgently needed in Hong Kong, claim researchers, after a new study found widespread deficiency and an association with cardiometabolic disease risk factors.
GNC set for China boom as Harbin pumps in $300m to become largest single shareholder
Supplement firm GNC looks set for considerable expansion in China, with Harbin Pharmaceutical Group Holding Co (Hayao) investing $300m to become the firm's largest single shareholder.
Nestlé Malaysia defends Milo over viral video accusations about sugar content
Nestlé Malaysia has responded to a viral online video, which claims its Milo drink contains 40% sugar, by stating: ‘The facts in this video are clearly misleading’.